Amebiasis: Clinical Presentations, Diagnostics, Treatment

Clinical Microbiology and Antimicrobial Chemotherapy. 2001; 3(3):215-222

​ Bronstein A.M., Malishev N.A., Lucshev V.I.
diarrhea protozoal infections amebiasis amebicides
Section
Diseases and Pathogens
Type
Journal article
Publication
Clinical Microbiology and Antimicrobial Chemotherapy. 2001; 3(3):215-222

Abstract

Amebiasis is a parasitic human disease caused by pathogenic strains of Entamoeba histolytica, and is one of the most important problems of public health in developing countries and one the main causes of death from parasitic intestinal diseases. The overview of amebiasis, its clinical presentations, treatment and prophylaxis are given. Approaches to the therapy of invasive and noninvasive amebiasis are presented. For infectious diseases clinicians, pediatricians, epidemiologist.

  • 1. Amoebiasis and its control. Report of a WHO Meeting. Bulletin of the World Health Organization 1985; 63:417-26.
  • 2. Cook G.C. Parasitic infections of the gastrointestinal tract: a worldwide clinical problem. Curr Opin Gastroenterol 1989; 5:126-39.
  • 3. Walsh J.A. Problems in recognition and diagnosis of amebiasis: estimation of the global magnitude of morbidity and mortality. Rev Infect Dis 1986; 8:228-38.
  • 4. Huston C.D., Petri W.A. Amebiasis: clinical implications of the recognition of Entamoeba dispar. Curr Infect Dis Rep 1999; 1:441-7.
  • 5. Evangelopoulos A., Spanakos G., Patsoula E., et al. A nested, multiplex, PCR assay for the simultaneous detection and differentiation of Entamoeba histolytica and Entamoeba dispar in faeces. Ann Trop Med Parasitol 2000; 94:233-40.
  • 6. Martinez-Palomo A. The pathogenesis of amoebiasis. Parasitol Today 1987; 3:111-8.
  • 7. Sargeaunt P.G. The reliability of Entamoeba histolytica zymodemes in clinical diagnosis. Parasitol Today 1987; 3:40-3.
  • 8. Sceto R.K., Rockey D.C. Amebic liver abscess: epidemiology, clinical features, and outcome. West J Med 1999; 170:104-9.
  • 9. Shamsuzzama S.M., Hague R., Hasin S.K., et al. Socioeconomic status, clinical features, laboratory and parasitological findings of hepatic amebiasis patients – a hospital based prospective study in Bangladesh. Southeast Asian J Trop Med Public Health 2000; 31:399-404.
  • 10. Hung C.C., Chen P.J., Hsieh S.M., et al. Invasive amoebiasis: an emerging parasitic disease in patients infected with HIV in an area endemic for amoebic infection. AIDS 1999; 13:2421-8.
  • 11. Lowther S.A., Dworkin M.S., Hanson D.L. Entamoeba histolytica/Entamoeba dispar infections in human immunodeficiency virus-infected patients in the United States. Clin Infect 2000; 30:955-9.
  • 12. Espinosa-Cantellano M., Martinez-Palomo A. Pathogenesis of intestinal amebiasis: from molecules to disease. Clin Microbiol Rev 2000; 13:318-31.
  • 13. Que X., Reed S.L. Cysteine proteinases and the pathogenesis of amoebiasis. Clin Microbiol Rev 2000; 13:196-206.
  • 14. Badalamenti S., Jameson J.E., Reddy K.R. Amebiasis. Curr Trea Options Gastroenterol 1999; 2:97-103.
  • 15. Ellyson J.H., Bezmalinovic Z., Parks S.N., Lewis F.R. Necrotizing amebic colitis: a frequently fatal complication. Am J Surg 1986; 152:21-6.
  • 16. Shukla V.K., Roy S.K., Vaidya M.P, Mehrotra M.L. Fulminant amebic colitis. Dis Colon Rectum 1986; 29:394-401.
  • 17. Abbas M.A., Mulligan D.C., Ramzan N.N., et al. Colonic perforation in unsuspected amebic colitis. Dig Dis Sci 2000; 45:1836-41.
  • 18. Ciftci A.O., Karnak I., Sencak M.E., et al. Spectrum of complicated intestinal amebiasis through resected specimens incidence and outcome. J Pediatr Surg 1999; 34:1369-73.
  • 19. Acuna-Soto R., Maguire J.H., Wirth D.F. Gender distribution in asymptomatic and invasive amebiasis. Am J Gastroenterol 2000; 95:1277-83.
  • 20. Hoffner R.J., Kilaghbian T., Esekogwi V.I., Henderson S.O. Common presentation of amebic liver abscess. Ann Emerg Med 1999; 34:351-5.
  • 21. Основные методы лабораторной диагностики паразитарных болезней. ВОЗ; 1994.
  • 22. WHO Model prescribing information. 2nd ed. Geneva: WHO; 1995.
  • 23. Shiruma T.M., Obata H., Karasawa E., et al. A recurrent case of amebic liver abscess seventeen years after the firs occurence. Kansenshogaku Zasshi 2000; 74: 585-8.
  • 24. Bassilys S., Farid Z., El-Masry N.A., Michail E.M. Treatment of intestinal E.histolytica and G.lamblia with metronidazole, tinidazole and ornidazole: a comparative study. J Trop Med Hyg 1987; 90:9-12.
  • 25. Bhatia S., Karnal D.R., Oak J.L. Randomized double-blind trial of metronidazole versus secnidazole in amebic liver abscess. Indian J Gastroenterol 1998; 17:53-4.
  • 26. Salles J.M., Bechara C., Tavares A.M., et al. Comparative study of the efficacy and tolerability of secnidazole suspension (single dose) and tinidazole suspension (two days dosage) in the treatment of amebiasis in children. Braz J Infect Dis 1999; 3:80-8.
  • 27. Akgun Y., Tacyildiz I.H., Celik Y. Amebic liver abscess: changing trends over 20 years. World J Surg 1999; 23:102-6.
  • 28. Hanna R.M., Dahniya M.H., Badr S.S., El-Batagy A. Percutaneus catheter drainage in drug-resistant amoebic liver abscess. Trop Med Int Health 2000; 5:578-81.
  • 29. Sharma M.P., Rai R.R., Acharya S.K., Ray J.C.S., Tandon B.N. Needle aspiration of amoebic liver abscesses. Am. J. Trop Med Hyg 1989; 40:384-9.
  • 30. Gatti S., Cevini C., Bermuzzi A.M., et al. Symptomatic and asymptomatic amoebiasis in two heterosexual couples. Ann Trop Med Parasitol 1999; 93:829-34.
  • 31. Профилактика кишечных паразитарных инвазий и борьба с ними. Сер техн докл ВОЗ 1988; 749.
Views
0 Abstract
0 PDF
0 Crossref citations
Shared